Skip to content
Important: This site presents data from the FDA Adverse Event Reporting System (FAERS). A report does not mean the drug caused the event. Full disclaimer.

ALPROSTADIL for Ventricular septal defect: Side Effects & Safety Data

Boost Your Natural Energy & Metabolism

Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.

Try Mitolyn Now

There are 8 adverse event reports in the FDA FAERS database where ALPROSTADIL was used for Ventricular septal defect.

Most Reported Side Effects for ALPROSTADIL

Side Effect Reports % Deaths Hosp.
Drug ineffective 1,412 50.4% 5 27
Wrong technique in product usage process 510 18.2% 0 5
Product quality issue 227 8.1% 0 10
Penile pain 164 5.9% 0 7
Off label use 112 4.0% 8 31
Penile burning sensation 92 3.3% 0 2
Erection increased 75 2.7% 0 5
Penile haemorrhage 62 2.2% 0 1
No adverse event 60 2.1% 0 0
Injection site pain 57 2.0% 0 1
Expired product administered 52 1.9% 0 3
Priapism 50 1.8% 0 15
Therapeutic product effect incomplete 47 1.7% 0 0
Product use issue 44 1.6% 6 5
Pain 43 1.5% 1 2

Other Indications for ALPROSTADIL

Erectile dysfunction (1,641) Product used for unknown indication (319) Prophylaxis (38) Heart disease congenital (29) Patent ductus arteriosus (26) Hypoplastic left heart syndrome (12) Prostate cancer (12) Sexual dysfunction (11) Peripheral ischaemia (8) Peripheral arterial occlusive disease (7)

Other Drugs Used for Ventricular septal defect

PALIVIZUMAB (177) AMBRISENTAN (57) FUROSEMIDE (10) TREPROSTINIL (9) SILDENAFIL (8) BOSENTAN (7)

Related Pages

ALPROSTADIL Full Profile All Ventricular septal defect Drugs ALPROSTADIL Demographics ALPROSTADIL Timeline